Marilyn K. Boardman
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 10
- Diabetes Management and Research 7
- Diabetes Management and Education 2
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
-
- Metabolism, Diabetes, and Cancer 6
- Co-authors
- Byron J. Hoogwerf (2 shared papers)John B. Buse (1 shared paper)Aijun Gao (1 shared paper)Michael A. Nauck (1 shared paper)Wayne H.-H. Sheu (1 shared paper)Lisa A. Porter (1 shared paper)Sylvia Shenouda (1 shared paper)Cory R. Heilmann (1 shared paper)
- Journals
- Journal of Diabetes Investigation (3 papers)Journal of Wound Care (1 paper)Clinical Epidemiology (1 paper)Diabetes Care (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesJapanTaiwan
In The Last Decade
Marilyn K. Boardman
12 papers receiving 1.1k citations
Marilyn K. Boardman's Hit Papers
Peers
Comparison fields: 5 of 66
- Endocrinology, Diabetes and Metabolism 1.0k
- Pharmacology 275
- Surgery 358
- Molecular Biology 470
- Family Practice 12
Countries citing papers authored by Marilyn K. Boardman
This map shows the geographic impact of Marilyn K. Boardman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn K. Boardman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn K. Boardman more than expected).
Fields of papers citing papers by Marilyn K. Boardman
This network shows the impact of papers produced by Marilyn K. Boardman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn K. Boardman. The network helps show where Marilyn K. Boardman may publish in the future.
Co-authors
The 25 scholars most cited alongside Marilyn K. Boardman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study Hit paper breakdown → | 2012 | 460 |
| 2 | 2011 | 296 | |
| 3 | 2014 | 134 | |
| 4 | 2012 | 67 | |
| 5 | 2010 | 48 | |
| 6 | 2017 | 27 | |
| 7 | 2012 | 22 | |
| 8 | 2010 | 16 | |
| 9 | 2012 | 11 | |
| 10 | 2019 | 9 | |
| 11 | 1993 | 9 | |
| 12 | 2013 | 2 |
About Marilyn K. Boardman
Marilyn K. Boardman is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pharmacology and Pathology and Forensic Medicine, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Pancreatic function and diabetes (2 papers), Diabetes Management and Education (2 papers), Pharmacology and Obesity Treatment (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper) and Alcohol Consumption and Health Effects (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.0k citations), Pharmacology (275 citations), Surgery (358 citations), Molecular Biology (470 citations) and Family Practice (12 citations). Marilyn K. Boardman has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include Byron J. Hoogwerf, John B. Buse, Aijun Gao, Michael A. Nauck, Wayne H.-H. Sheu, Lisa A. Porter, Sylvia Shenouda, Cory R. Heilmann, Guntram Schernthaner and Thomas Först. Their work appears in journals such as Journal of Diabetes Investigation, Journal of Wound Care, Clinical Epidemiology, Diabetes Care and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.